No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
Truist Financial Maintains Insmed(INSM.US) With Buy Rating, Announces Target Price $108
BofA Securities Maintains Insmed(INSM.US) With Buy Rating, Raises Target Price to $96
Insmed Is Maintained at Buy by B of A Securities
Express News | Insmed Inc : BofA Global Research Raises Price Objective to $96 From $92
Mizuho Securities Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $96
RBC Capital Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $100